This study focuses on the comparison between different brands and their market share of acyclovir. Acyclovir, a widely used antiviral drug, is available in multiple brands with varying strengths, prices, and market performance. The objective of this work is to evaluate the availability, pricing, and sales trends of different acyclovir brands across selected medical stores. Data were collected from various medical stores including Ganga Medical, Vidharbha Medical, Maharashtra Medical, Shri Krupa Medical, Subhedar Medical, Adishakti Medical, Bora Medical, Praful Medical, Mahavir Medical, and Jeevan Medical. The study analyzed the monthly sales (November to February) of six major brands: Zovirax (GSK), Acivir (Cipla), Acyprove, Acloveer, Occuvir, and Aclorex. The results indicate that Acivir (Cipla) consistently shows the highest sales in most medical stores, suggesting strong market dominance and customer preference. Zovirax (GSK) also demonstrates significant sales but is comparatively lower due to higher pricing. Other brands such as Acyprove, Acloveer, Occuvir, and Aclorex show moderate to lower market share, possibly influenced by price variation and brand awareness. Overall, the study highlights that price, brand reputation, and availability significantly influence the market share of acyclovir brands in the region. This analysis can be useful for pharmacists, healthcare professionals, and pharmaceutical companies to understand market trends and optimize product positioning.
*1Tejas P. Talan, 2Gayatri Waghmare, 3Dr. Karishma A. Nikose, 4Dr. Rahul S. Bijwar (Tue,) studied this question.